Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call

Rhea-AI Summary

Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), has announced it will release its fourth quarter and full year 2024 financial results before market opens on Monday, March 3, 2025. The company will host a conference call at 9:00 am ET on the same day, featuring a financial results review and a question-and-answer session.

Participants interested in joining the earnings call should register through the Fortrea Investor Relations website and are advised to join at least 10 minutes before the call starts. A replay of the conference call will be made available on the events and presentations section of the company's Investor Relations website after the event.

DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2024 financial results before the market opens on Monday, March 3, 2025. Fortrea will host a conference call at 9:00 am ET that day to review its financial results and conduct a question-and-answer session.

To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link.

A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).

Fortrea Contacts

Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com

Sue Zaranek (Media) – 919-943-5422, media@fortrea.com

Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com

FAQ

When will Fortrea (FTRE) release its Q4 and full year 2024 earnings?

Fortrea will release its Q4 and full year 2024 financial results before the market opens on Monday, March 3, 2025.

What time is Fortrea's Q4 2024 earnings conference call?

Fortrea's Q4 2024 earnings conference call is scheduled for 9:00 am ET on March 3, 2025.

How can investors access Fortrea's Q4 2024 earnings call?

Investors can access the call by registering through the Fortrea Investor Relations website. It's recommended to join 10 minutes before the start time.

Will there be a replay available for Fortrea's Q4 2024 earnings call?

Yes, a replay of the live conference call will be available shortly after the event concludes on the events and presentations section of the Fortrea Investor Relations website.